carbostyril has been researched along with Diabetes Mellitus in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.00) | 18.2507 |
| 2000's | 9 (45.00) | 29.6817 |
| 2010's | 6 (30.00) | 24.3611 |
| 2020's | 4 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bengtson, CD; He, J; Kim, MD; Salathe, MA | 1 |
| Abely, M; Bounyar, L; Chatron, E; Chiron, R; Cosson, L; Dominique, S; Durieu, I; Gerardin, M; Kessler, L; Kessler, R; Mankikian, J; Melly, L; Misgault, B; Porzio, M; Reynaud, Q; Ronsin-Pradel, O; Touzet, S; Troussier, F; Weiss, L | 1 |
| Chen, S; Gaines, H; Jones, KR; Lim, J; Medhi, NF; Scofield, RH | 1 |
| Bojanowski, CM; Klingsberg, RC; Wilson, SM | 1 |
| Norris, AW | 1 |
| Grossman, F; Hassan, M; Meyer, K; O'Day, K; Rajagopalan, K | 1 |
| Bellin, MD; Billings, J; Dunitz, J; Laguna, T; Leschyshyn, J; Moran, A; Regelmann, W | 1 |
| Baker, RA; Citrome, L; Hebden, T; Kalsekar, I | 1 |
| Hayes, D; McCoy, KS; Sheikh, SI | 1 |
| Gaikwad, AB; Kadakol, A; Kumar, GS; Malek, V; Pandey, A | 1 |
| Barnett, AH; Knapp, M; L'Italien, GJ; Loze, JY; Millar, HL; van Baardewijk, M | 1 |
| Bogers, JP; Starrenburg, FC | 1 |
| DeLorenze, G; L'Italien, G; McQuade, R; Newcomer, J; Oliveria, SA; Quesenberry, CP; Tsai, AL; Willey, VJ; Yood, MU | 1 |
| Cohen, D; Correll, CU | 1 |
| Dubois, D | 1 |
| De Hert, M; Hanssens, L; Peuskens, J; Scheen, A; Van Eyck, D; van Winkel, R; Wampers, M | 1 |
| Lagu, B; Lebedev, R; Pelton, PD; Pio, B; Yang, M | 1 |
| Wooten, J | 1 |
| Blonde, L; Gutterman, EM; Hanssens, L; Kan, HJ; Kim, MS; L'Italien, GJ; McQuade, RD | 1 |
| Hartmann, C; McIntire, WS | 1 |
5 review(s) available for carbostyril and Diabetes Mellitus
| Article | Year |
|---|---|
A review of real-world data on the effects of aripiprazole on weight and metabolic outcomes in adults.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Carbohydrate Metabolism; Diabetes Mellitus; Glucose Metabolism Disorders; Humans; Hyperlipidemias; Insulin Resistance; Lipid Metabolism; Overweight; Piperazines; Quinolones; Weight Gain | 2014 |
FoxO1 Inhibitors: The Future Medicine for Metabolic Disorders?
Topics: Animals; Diabetes Complications; Diabetes Mellitus; Forkhead Box Protein O1; Humans; Metabolic Diseases; Obesity; Quinolones; Therapies, Investigational | 2016 |
How can antipsychotics cause Diabetes Mellitus? Insights based on receptor-binding profiles, humoral factors and transporter proteins.
Topics: Adiponectin; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Blood Glucose; Clozapine; Diabetes Mellitus; Humans; Leptin; Obesity; Olanzapine; Piperazines; Quinolones; Receptor, Muscarinic M3; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D2; Receptors, Histamine; Serotonin 5-HT1 Receptor Agonists; Thiazoles; Weight Gain | 2009 |
Toxicology and overdose of atypical antipsychotic medications in children: does newer necessarily mean safer?
Topics: Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Benzodiazepines; Cardiomyopathies; Child; Clozapine; Diabetes Mellitus; Dibenzothiazepines; Drug Interactions; Drug Overdose; Dry Eye Syndromes; Humans; Hyperlipidemias; Hypotension; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Seizures; Thiazoles | 2005 |
Metabolic effects of the atypical antipsychotics.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Diabetes Mellitus; Dibenzothiazepines; Dyslipidemias; Glucose Metabolism Disorders; Humans; Insulin Resistance; Mental Disorders; Obesity; Olanzapine; Phenothiazines; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Thiazoles | 2007 |
3 trial(s) available for carbostyril and Diabetes Mellitus
| Article | Year |
|---|---|
Insulin secretion improves in cystic fibrosis following ivacaftor correction of CFTR: a small pilot study.
Topics: Adolescent; Adult; Amino Acid Substitution; Aminophenols; Child; Cross-Sectional Studies; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Diabetes Mellitus; Female; Glucose Intolerance; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Insulin-Secreting Cells; Male; Middle Aged; Mutation; Pilot Projects; Prediabetic State; Quinolones | 2013 |
UK cost-consequence analysis of aripiprazole in schizophrenia: diabetes and coronary heart disease risk projections (STAR study).
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antipsychotic Agents; Aripiprazole; Coronary Disease; Cost of Illness; Costs and Cost Analysis; Diabetes Mellitus; Female; Follow-Up Studies; Health Resources; Health Services; Humans; Male; Middle Aged; Piperazines; Prospective Studies; Quinolones; Risk Assessment; Risk Factors; Schizophrenia; United Kingdom; Young Adult | 2009 |
Predicted risk of diabetes and coronary heart disease in patients with schizophrenia: aripiprazole versus standard of care.
Topics: Adult; Algorithms; Aripiprazole; Blood Glucose; Body Mass Index; Cholesterol, HDL; Cholesterol, LDL; Comorbidity; Coronary Disease; Diabetes Mellitus; Female; Humans; Hypertension; Incidence; Male; Piperazines; Prevalence; Prospective Studies; Quinolones; Risk Assessment; Risk Factors; Schizophrenia | 2008 |
12 other study(ies) available for carbostyril and Diabetes Mellitus
| Article | Year |
|---|---|
Cystic Fibrosis-related Diabetes Is Associated with Worse Lung Function Trajectory despite Ivacaftor Use.
Topics: Adolescent; Adult; Age Factors; Aminophenols; Chloride Channel Agonists; Cohort Studies; Cystic Fibrosis; Diabetes Mellitus; Female; Forced Expiratory Volume; Humans; Male; Quinolones; Young Adult | 2021 |
Effect of one-year lumacaftor-ivacaftor treatment on glucose tolerance abnormalities in cystic fibrosis patients.
Topics: Adolescent; Adult; Aminophenols; Aminopyridines; Benzodioxoles; Blood Glucose; Child; Cystic Fibrosis; Diabetes Mellitus; Drug Administration Schedule; Drug Combinations; Female; Glucose Intolerance; Glucose Tolerance Test; Humans; Male; Middle Aged; Prospective Studies; Quinolones; Young Adult | 2020 |
Effect of CFTR modulator therapy on cystic fibrosis-related diabetes.
Topics: Adult; Aminophenols; Blood Glucose; Blood Glucose Self-Monitoring; Chloride Channel Agonists; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Diabetes Mellitus; Humans; Insulin; Quinolones | 2021 |
CFTR modulator therapy improves cystic fibrosis-related diabetes. But how?
Topics: Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Diabetes Mellitus; Humans; Indoles; Quinolones | 2021 |
Is Cystic Fibrosis-related Diabetes Reversible? New Data on CFTR Potentiation and Insulin Secretion.
Topics: Aminophenols; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Diabetes Mellitus; Humans; Incretins; Insulin Secretion; Quinolones | 2019 |
Cost-effectiveness of lurasidone vs aripiprazole among patients with schizophrenia who have previously failed on an atypical antipsychotic: an indirect comparison of outcomes from clinical trial data.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Cardiovascular Diseases; Clinical Trials as Topic; Clozapine; Comorbidity; Cost-Benefit Analysis; Diabetes Mellitus; Hospitalization; Humans; Isoindoles; Lurasidone Hydrochloride; Markov Chains; Models, Economic; Outcome Assessment, Health Care; Piperazines; Quinolones; Recurrence; Schizophrenia; Thiazoles; United States | 2013 |
Resolution of cystic fibrosis-related diabetes with ivacaftor therapy.
Topics: Adult; Aminophenols; Cystic Fibrosis; Diabetes Mellitus; Humans; Hypoglycemic Agents; Male; Quinolones | 2014 |
The incidence of diabetes in atypical antipsychotic users differs according to agent--results from a multisite epidemiologic study.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Cohort Studies; Diabetes Mellitus; Female; Humans; Male; Mental Disorders; Middle Aged; Olanzapine; Piperazines; Quinolones; Retrospective Studies; Thiazoles; United States | 2009 |
Second-generation antipsychotic-associated diabetes mellitus and diabetic ketoacidosis: mechanisms, predictors, and screening need.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Diabetes Mellitus; Diabetic Ketoacidosis; Dibenzothiazepines; Humans; Mass Screening; Olanzapine; Piperazines; Predictive Value of Tests; Prospective Studies; Quetiapine Fumarate; Quinolones; Severity of Illness Index | 2009 |
Reversibility of antipsychotic treatment-related diabetes in patients with schizophrenia: a case series of switching to aripiprazole.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Diabetes Mellitus; Humans; Middle Aged; Piperazines; Quinolones; Schizophrenia | 2006 |
Dihydro-[1H]-quinolin-2-ones as retinoid X receptor (RXR) agonists for potential treatment of dyslipidemia.
Topics: Animals; Diabetes Mellitus; Disease Models, Animal; Dyslipidemias; Hypoglycemic Agents; Quinolones; Rats; Rats, Sprague-Dawley; Retinoid X Receptors; Structure-Activity Relationship | 2007 |
Amine-oxidizing quinoproteins.
Topics: Amino Acid Sequence; Coenzymes; Copper; Diabetes Mellitus; Dihydroxyphenylalanine; Electron Spin Resonance Spectroscopy; Enzyme Inhibitors; Heart Failure; Humans; Indolequinones; Liver Cirrhosis; Lysine; Menkes Kinky Hair Syndrome; Metalloproteins; Mixed Function Oxygenases; Models, Molecular; Molecular Sequence Data; Oxidation-Reduction; Oxidoreductases Acting on CH-NH Group Donors; PQQ Cofactor; Protein-Lysine 6-Oxidase; Quinolones; Quinones; Semicarbazides; Sequence Homology, Amino Acid; Spectrum Analysis, Raman; Stereoisomerism; Substrate Specificity; Tryptophan | 1997 |